Medochemie

Medochemie

Medochemie Ltd is a multinational generics pharmaceutical and consumer healthcare company headquartered in Limassol, Cyprus.[1] Medochemie develops, licenses, manufactures, markets, and distributes branded generic products as well as their own patented brands.[2][3]

Quick Facts Company type, Industry ...

History

Medochemie was established in 1976 by a Cypriot entrepreneur Dr. Andreas Pittas with eight employees and three machines: for tablet making, capsule filling and packaging.[4] Medochemie is a founding member of the European Generic Medicines Association (EGA).[5][6]

Operations

Medochemie employed 1,250 people in 2009.[7] Medochemie has thirteen manufacturing plants and facilities. Nine are located in Cyprus, one in the Netherlands, and three in Vietnam. The company maintains 3,800 marketing authorization licenses for 630 different pharmaceutical products, classified in over 10 therapeutic categories.[8] Its global headquarters are at Medochemie House in Limassol's industrial area.[9][10]


References

  1. "Company Profile – Medochemie". PharmiWeb.com. 2013. Retrieved 24 April 2013.
  2. "Medochemie: About". Medochemie. 2013. Archived from the original on 9 April 2013. Retrieved 4 August 2013.
  3. "Amlodipine Medochemie". Drugs.com. 2013. Retrieved 4 August 2013.
  4. "Medochemie Cyprus exports reach €100 mln". FinancialMirror.com. 2009. Retrieved 4 May 2013.
  5. "Medochemie: History". CareerBuilder.com. 2013. Retrieved 4 October 2013.
  6. "European Generic Medicines Association Members". EGAgenerics.com. 2013. Archived from the original on 12 October 2013. Retrieved 4 October 2013.
  7. "Medochemie About" Archived 9 April 2013 at the Wayback Machine Medochemie, 3 November 2009
  8. "Medochemie: History". CareerBuilder.com. 2013. Retrieved 4 October 2013.
  9. "Drugs company pledges continuous supplies". Cyprus-mail.com. 2013. Archived from the original on 22 May 2013. Retrieved 4 November 2013.

Share this article:

This article uses material from the Wikipedia article Medochemie, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.